14:59 EDT Finch Therapeutics trading halted, volatility trading pause
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on FNCH:
- Finch Announces Reverse Stock Split of Common Stock
- Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
- Finch Therapeutics appoints Matthew Blischak CEO
- Finch enters CP101 clinical trial agreement with Brigham and Women’s Hospital
- Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement